Biotest GmbH & Co. KGaA (HAM:BIO0)
33.00
0.00 (0.00%)
At close: Jul 2, 2026
Biotest GmbH & Co. KGaA Revenue
In the year 2025, Biotest GmbH & Co. KGaA had annual revenue of 648.90M EUR, down -10.64%. Biotest GmbH & Co. KGaA had revenue of 124.20M in the quarter ending March 31, 2025, a decrease of -42.29%.
Revenue
648.90M
Revenue Growth
-16.95%
P/S Ratio
2.01
Revenue / Employee
240.51K
Employees
2,698
Market Cap
1.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 648.90M | -77.30M | -10.64% |
| Dec 31, 2024 | 726.20M | 41.60M | 6.08% |
| Dec 31, 2023 | 684.60M | 168.50M | 32.65% |
| Dec 31, 2022 | 516.10M | 500.00K | 0.10% |
| Dec 31, 2021 | 515.60M | 31.40M | 6.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Darwin AG | 54.30M |
| Paion AG | 14.81M |
| 2invest AG | 8.89M |
| MagForce AG | 1.08M |
| Biomark Diagnostics | 57.01K |
| co.don AG | 22.00K |
| bioXXmed AG | 20.49K |